WordNet

to remain unmolested, undisturbed, or uninterrupted -- used only in infinitive form; "let her be"
work in a specific place, with a specific subject, or in a specific function; "He is a herpetologist"; "She is our resident philosopher" (同)follow
have life, be alive; "Our great leader is no more"; "My grandfather lived until the end of war" (同)live
be identical to; be someone or something; "The president of the company is John Smith"; "This is my house"
happen, occur, take place; "I lost my wallet; this was during the visit to my parents house"; "There were two hundred people at his funeral"; "There was a lot of noise in the kitchen"
have the quality of being; (copula, used with an adjective or a predicate noun); "John is rich"; "This is not a good answer"
occupy a certain position or area; be somewhere; "Where is my umbrella?" "The toolshed is in the back"; "What is behind this behavior?"
spend or use time; "I may be an hour"
stake on the outcome of an issue; "I bet $100 on that new horse"; "She played all her money on the dark horse" (同)wager, play
the act of gambling; "he did it on a bet" (同)wager
maintain with or as if with a bet; "I bet she will be there!" (同)wager
second in order of importance; "the candidate, considered a beta male, was perceived to be unable to lead his party to victory"
the 2nd letter of the Greek alphabet
preliminary or testing stage of a software or hardware product; "a beta version"; "beta software"
the 20th letter of the Roman alphabet (同)t

PrepTutorEJDIC

《連結語として補語を伴なって…『である』,…だ,…です / 《位置・場所を表す語句を伴って》(…に)『ある』,いる(occupy a place or situation) / 〈物事が〉『存在する』,ある(exist);〈生物が〉生存する,生きている(live) / 行われる,起こる,発生する(take place, occur) / 存続する,そのままでいる(remain as before) / 《『be to』 do》 / …する予定である,…することになっている / …すべきだ / 《受動態の不定詞を伴って》…できる / 《命令》…するのだ / 《条件節に》…する意図がある / 《『if…were to』 do》…するとしたなら / 《『be』 do『ing』》《進行形》 / 《進行中の動作》…している,しつつある / 《近い未来》…しようとしている,するつもり / 《動作の反復》(いつも)…している / 《『be』+『他動詞の過去分詞』》《受動態》…される,されている / 《『be』+『自動詞の過去分詞』》《完了形》…した[状態にある]
『かけ』・(…との)かけ《+『with』+『名』》 / かけた物(金) / かけの対象 / 〈金・物〉'を'『かける』 / (かけ事・ゲームなどで)〈人〉‘と'『かけをする』《+『名』〈人〉+『on』+『名』》 / (…に)『かける』《+『on』(『against』)+『名』(one's do『ing』)》
ベータ(ギリシア語アルファベットの第2文字;B,β;英語のB,b に遭当)
tritiumの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 甲状腺刺激ホルモン（TSH）分泌下垂体腺腫 thyrotropin tsh secreting pituitary adenomas
2. 甲状腺刺激ホルモンおよび甲状腺刺激ホルモン放出ホルモンに対する抵抗性 resistance to thyrotropin and thyrotropin releasing hormone
3. 中枢性甲状腺機能低下症 central hypothyroidism
4. 新生児グレーヴス病の評価およびマネージメント evaluation and management of neonatal graves disease
5. 甲状腺結節の診断的アプローチおよび治療 diagnostic approach to and treatment of thyroid nodules

English Journal

Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.

Mohseni F1, Mohajeri-Tehrani MR, Larijani B, Hamidi Z.Author information 1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.AbstractLow BMDs, short stature, hypogonadism, subclinical hypothyroidism, and IFG are found in 3.3, 10, 33, 16.6, 6.6, and 26.6 % of 30 pediatric β thalassemia major patients, respectively. Age is related with low Z-scores. Short stature and hypogonadism patients were older. These patients' monitoring in late childhood and early teenage for these complications is recommended.
Archives of osteoporosis.Arch Osteoporos.2014 Dec;9(1):174. doi: 10.1007/s11657-014-0174-3. Epub 2014 Mar 21.
Low BMDs, short stature, hypogonadism, subclinical hypothyroidism, and IFG are found in 3.3, 10, 33, 16.6, 6.6, and 26.6 % of 30 pediatric β thalassemia major patients, respectively. Age is related with low Z-scores. Short stature and hypogonadism patients were older. These patients' monitoring in
PMID 24652076

Abnormal liver function test in hydatidiform moles: a retrospective study comparing the hyperthyroid state and the euthyroid state.

Kucukoglu ME1, Dulger AC, Aslan M, Olmez S, Guler A, Aldemir MN, Ebinc S, Karadas S, Demirkıran D.Author information 1Department of Gastroenterology .AbstractAbstract Introduction: The effect of a hyperthyroid or euthyroid state on liver function tests in patients with hydatidiform moles (HM) is not known. The aim of this study was to determine the effect of hyperthyroidism on liver transaminases in HM. Patients and methods: We retrospectively reviewed aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in 80 patients with HM (23 complete moles and 57 partial moles). Results: Of the 80 HM patients, 52 (65%) were euthyroid and 28 (35%) were hyperthyroid. The number of gravida and the levels of serum β-human chorionic gonadotropin (β-HCG), AST, and ALT were significantly higher in the hyperthyroid state than in the euthyroid state (p = 0.033, p = 0.001, p = 0.001 and p = 0.001; respectively). Number of gravida, serum TSH and total T4 were significantly higher in complete HM than partial HM (p < 0.05, p < 0.001, p < 0.05; respectively). Conclusions: Our results demonstrated that HM-related β-HCG may activate thyroid cells via TSH-related signalling, resulting in the release of high levels of FT4, FT3, TT3 and TT4, and a subsequent decrease in TSH.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.Gynecol Endocrinol.2014 Apr;30(4):287-9. doi: 10.3109/09513590.2013.875993. Epub 2014 Jan 30.
Abstract Introduction: The effect of a hyperthyroid or euthyroid state on liver function tests in patients with hydatidiform moles (HM) is not known. The aim of this study was to determine the effect of hyperthyroidism on liver transaminases in HM. Patients and methods: We retrospectively reviewed a
PMID 24479884

Blood thrombogenicity is independently associated with serum TSH levels in post non ST elevation acute coronary syndrome.

Viswanathan G1, Balasubramaniam K, Hardy R, Marshall S, Zaman A, Razvi S.Author information 1Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK;AbstractContext: Higher serum TSH levels, both within the reference range and in those with subclinical hypothyroidism (SCH), have been associated with increased risk of atherosclerosis and cardiovascular (CV) events in a number of cross-sectional and longitudinal studies. Objective: to evaluate blood thrombogenicity (BT) in patients post non-ST elevation acute coronary syndrome (NSTE-ACS) with relation to their thyroid function. Design, patients and outcome measure: Seventy patients one week after troponin positive NSTE-ACS who had been treated with optimal antiplatelet and secondary prevention therapy were studied. Patients with known thyroid disease or on medications affecting thyroid function were excluded. BT was assessed using the ex-vivo Badimon perfusion chamber. Results: Serum TSH was associated with higher thrombus burden (β=0.30; p=0.01) independent of other well-established CV risk factors. Patients with SCH (n=12; 17%) had a higher thrombus burden than euthyroid individuals as evidenced by the area of the thrombus: mean (SD) [23,608 (10,498) vs 16,661 (10,902) μ 2/mm, p=0.02]. However, this association was not evident when the analysis was limited to patients with serum TSH within the reference range. In addition, neither serum free T4 nor free T3 had any significant association with thrombus area. Conclusion: Serum TSH levels, particularly in the subclinical hypothyroid range, are associated with higher thrombus burden despite optimal recommended secondary prevention therapy following NSTE-ACS. This may explain the higher CV risk seen in SCH patients. Future trials to assess the effect of individualised anti-thrombotic as well as thyroid hormone replacement therapy to reduce atherothrombotic risk in this population are needed.
The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2014 Mar 14:jc20133062. [Epub ahead of print]
Context: Higher serum TSH levels, both within the reference range and in those with subclinical hypothyroidism (SCH), have been associated with increased risk of atherosclerosis and cardiovascular (CV) events in a number of cross-sectional and longitudinal studies. Objective: to evaluate blood throm
PMID 24628547

Japanese Journal

エルクTSHβ鎖のcDNAクローニングと下垂体糖タンパク質ホルモン遺伝子発現の季節変動

Clark Rena J.,Furlan Michael A.,Chedrese P. Jorge
Journal of Reproduction and Development 51(3), 385-392, 2005
… We report the elk (Cervus elaphus) thyroid stimulating hormone (TSH) β-subunit cDNA cloning, nucleotide and deduced amino acid sequences. … The TSH β-subunit cDNA was obtained by RT-PCR of polyadenylated pituitary RNA. … The deduced elk TSH β-subunit peptide chain shares between 93 to 99% sequence similarities with the reported TSH β-subunit of a sub-set of related species. …
NAID 130000054728

<Original article>In situ Hybridization Analysis of Neuronatin mRNA in the Human Pituitary Gland and Pituitary Tumors

ONO Hideko,MORII Ken,TAMURA Tetsuro,TANAKA Ryuichi
Acta medica et biologica 51(1), 25-30, 2003-03
… In IHC, antibodies to GH, PRL, FSH-beta, LH-beta, TSH-beta, and ACTH were used. …
NAID 110004461758

Low TSH congenital hypothyroidism : identification of a novel mutation of the TSH beta-subunit gene in one sporadic case (C85R) and of mutation Q49stop in two siblings with congenital hypothyroidism

SERTEDAKI A
Pediatr Res 52, 935-941, 2002
NAID 30027170970

Related Pictures

tsh 2.1.2 beta edition download Hormone, beta Subunit; TSH, beta Subunit hormone is unique to tsh beta chain Western blot - Anti-TSH beta antibody detection of human tsh beta by western TSH beta in Human Pituitary. tsh alpha orange tsh beta magenta and the

★リンクテーブル★

リンク元	「甲状腺刺激ホルモンβ鎖」「thyrotropin beta subunit」「thyroid-stimulating hormone beta」
関連記事	「TS」「T」「beta」「be」「TSH」